Common variable immunodeficiency with granulomatous-lymphocytic interstitial lung disease and preceding neurological involvement: a case-report.
Biopsy
Brain
/ diagnostic imaging
Central Nervous System Diseases
/ diagnosis
Common Variable Immunodeficiency
/ complications
Female
Granuloma
/ diagnosis
Humans
Lung
/ diagnostic imaging
Lung Diseases, Interstitial
/ diagnosis
Magnetic Resonance Imaging
Middle Aged
Sarcoidosis
/ diagnosis
Tomography, X-Ray Computed
Common variable immunodeficiency
Granulomatous-lymphocytic interstitial lung disease
Sarcoidosis
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
31 Jul 2020
31 Jul 2020
Historique:
received:
24
12
2019
accepted:
13
07
2020
entrez:
2
8
2020
pubmed:
2
8
2020
medline:
18
5
2021
Statut:
epublish
Résumé
Common variable immunodeficiency (CVID) is a group of heterogeneous primary immunodeficiencies characterised by a dysregulated and impaired immune response. In addition to an increased susceptibility to infection, it is also associated with noninfectious autoimmune and lymphoproliferative complications. CVID is rarely associated with neurological complications. Pulmonary involvement is more common, and patients can develop an interstitial lung disease known as granulomatous-lymphocytic interstitial lung disease (GLILD). A 50-year-old Caucasian female with a history of Evans syndrome (idiopathic thrombocytopaenic purpura and autoimmune haemolytic anaemia) and hypogammaglobulinaemia initially presented to the neurology clinic with marked cerebellar ataxia and headaches. Following extensive investigation (which included brain biopsy), she was diagnosed with neuro-sarcoidosis and her symptoms resolved following treatment with immunosuppressive therapy. Over the following 10 years, she was extensively investigated for recurrent pulmonary infections and abnormal radiological findings, which included pulmonary nodules, infiltrates and splenomegaly. Subsequently, she was referred to an immunology clinic, where immunoglobulin replacement treatment was started for what was ultimately considered to be CVID. Shortly afterwards, evaluation of her clinical, radiological and histological findings at a specialist interstitial lung disease clinic led to a diagnosis of GLILD. CVID is a condition which should be suspected in patients with immunodeficiency and recurrent infections. Concomitant autoimmune disorders such as haemolytic anaemia and immune thrombocytopenia may further support the diagnosis. As illustrated in this case, there is a rare association between CVID and inflammatory involvement of the neurological system. Respiratory physicians should also suspect CVID with associated GLILD in patients with apparent pulmonary granulomatous disease and recurrent infections. In addition, this case also highlights the challenge of diagnosing CVID and its associated features, and how the definitive exclusion of other pathologies such as malignancy, mycobacterial infection and lymphoma is required as part of this diagnostic process.
Sections du résumé
BACKGROUND
BACKGROUND
Common variable immunodeficiency (CVID) is a group of heterogeneous primary immunodeficiencies characterised by a dysregulated and impaired immune response. In addition to an increased susceptibility to infection, it is also associated with noninfectious autoimmune and lymphoproliferative complications. CVID is rarely associated with neurological complications. Pulmonary involvement is more common, and patients can develop an interstitial lung disease known as granulomatous-lymphocytic interstitial lung disease (GLILD).
CASE PRESENTATION
METHODS
A 50-year-old Caucasian female with a history of Evans syndrome (idiopathic thrombocytopaenic purpura and autoimmune haemolytic anaemia) and hypogammaglobulinaemia initially presented to the neurology clinic with marked cerebellar ataxia and headaches. Following extensive investigation (which included brain biopsy), she was diagnosed with neuro-sarcoidosis and her symptoms resolved following treatment with immunosuppressive therapy. Over the following 10 years, she was extensively investigated for recurrent pulmonary infections and abnormal radiological findings, which included pulmonary nodules, infiltrates and splenomegaly. Subsequently, she was referred to an immunology clinic, where immunoglobulin replacement treatment was started for what was ultimately considered to be CVID. Shortly afterwards, evaluation of her clinical, radiological and histological findings at a specialist interstitial lung disease clinic led to a diagnosis of GLILD.
CONCLUSION
CONCLUSIONS
CVID is a condition which should be suspected in patients with immunodeficiency and recurrent infections. Concomitant autoimmune disorders such as haemolytic anaemia and immune thrombocytopenia may further support the diagnosis. As illustrated in this case, there is a rare association between CVID and inflammatory involvement of the neurological system. Respiratory physicians should also suspect CVID with associated GLILD in patients with apparent pulmonary granulomatous disease and recurrent infections. In addition, this case also highlights the challenge of diagnosing CVID and its associated features, and how the definitive exclusion of other pathologies such as malignancy, mycobacterial infection and lymphoma is required as part of this diagnostic process.
Identifiants
pubmed: 32736614
doi: 10.1186/s12890-020-01231-6
pii: 10.1186/s12890-020-01231-6
pmc: PMC7393898
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
205Références
Clin Respir J. 2018 Jan;12(1):337-343
pubmed: 27243233
Cent Eur J Immunol. 2015;40(1):83-90
pubmed: 26155188
J Allergy Clin Immunol. 2007 Oct;120(4):776-94
pubmed: 17952897
J Clin Immunol. 2016 Nov;36(8):793-800
pubmed: 27704236
BMJ Case Rep. 2012 Aug 08;2012:
pubmed: 22878981
Blood. 2008 Jul 15;112(2):277-86
pubmed: 18319398
Clin Exp Immunol. 2013 Nov;174(2):203-11
pubmed: 23859429
Pract Neurol. 2015 Feb;15(1):49-52
pubmed: 25335879
Clin Immunol. 2008 Jul;128(1):18-22
pubmed: 18486555
Ann Allergy Asthma Immunol. 2017 May;118(5):614-620
pubmed: 28254202
Ann Intern Med. 1997 Oct 15;127(8 Pt 1):613-7
pubmed: 9341059
Ideggyogy Sz. 2011 Nov 30;64(11-12):405-8
pubmed: 22611619
Clin Immunol. 1999 Jul;92(1):34-48
pubmed: 10413651
Medicine (Baltimore). 1996 Sep;75(5):251-61
pubmed: 8862347
J Neurol. 2008 Nov;255(11):1821-4
pubmed: 18677641
Semin Respir Crit Care Med. 2014 Jun;35(3):330-5
pubmed: 25007085
Eur J Radiol. 2005 Jun;54(3):359-64
pubmed: 15899336
J Med Case Rep. 2011 Jul 19;5:319
pubmed: 21771303
Front Neurol. 2018 Nov 30;9:1031
pubmed: 30555409
Clin Immunol. 2010 Feb;134(2):97-103
pubmed: 19900842
J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):938-945
pubmed: 28351785
Ann Thorac Surg. 2007 Mar;83(3):1140-4
pubmed: 17307476